These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 35933795)
1. Menopausal hormone therapy with conjugated equine estrogen is associated with a higher risk of hemorrhagic stroke than therapy with estradiol: a retrospective population-based cohort study. Chang WC; Wang JH; Ding DC Maturitas; 2022 Nov; 165():72-77. PubMed ID: 35933795 [TBL] [Abstract][Full Text] [Related]
2. Conjugated equine estrogen used in postmenopausal women associated with a higher risk of stroke than estradiol. Chang WC; Wang JH; Ding DC Sci Rep; 2021 May; 11(1):10801. PubMed ID: 34031535 [TBL] [Abstract][Full Text] [Related]
3. Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice. Panay N; Nappi RE; Stute P; Palacios S; Paszkowski T; Kagan R; Archer DF; Héroux J; Boolell M Maturitas; 2023 Jun; 172():23-31. PubMed ID: 37084589 [TBL] [Abstract][Full Text] [Related]
4. Relationship between menopausal hormone therapy and breast cancer: A nationwide population-based cohort study. Yuk JS Int J Gynaecol Obstet; 2024 Aug; 166(2):735-744. PubMed ID: 38469634 [TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: A nationwide cohort study. Tsai WC; Haung YB; Kuo HF; Tang WH; Hsu PC; Su HM; Lin TH; Chu CS; Jhuo SJ; Lee KT; Sheu SH; Chen CY; Wu MT; Lai WT Sci Rep; 2016 Apr; 6():24132. PubMed ID: 27052889 [TBL] [Abstract][Full Text] [Related]
7. Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers. Blondon M; van Hylckama Vlieg A; Wiggins KL; Harrington LB; McKnight B; Rice KM; Rosendaal FR; Heckbert SR; Psaty BM; Smith NL J Thromb Haemost; 2014 Jun; 12(6):879-86. PubMed ID: 24628832 [TBL] [Abstract][Full Text] [Related]
8. Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen. Yue W; Wang J; Atkins KA; Bottalico L; Mesaros C; Blair IA; Santen RJ Int J Cancer; 2018 Sep; 143(5):1259-1268. PubMed ID: 29577272 [TBL] [Abstract][Full Text] [Related]
9. Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins. Graham S; Archer DF; Simon JA; Ohleth KM; Bernick B Gynecol Endocrinol; 2022 Nov; 38(11):891-910. PubMed ID: 36075250 [No Abstract] [Full Text] [Related]
10. Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study. Crandall CJ; Hovey KM; Andrews C; Cauley JA; Stefanick M; Shufelt C; Prentice RL; Kaunitz AM; Eaton C; Wactawski-Wende J; Manson JE Menopause; 2017 Oct; 24(10):1145-1153. PubMed ID: 28697036 [TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study. Yuk JS; Park JY PLoS One; 2023; 18(12):e0294356. PubMed ID: 38048308 [TBL] [Abstract][Full Text] [Related]
12. Comparative venous thromboembolic safety of oral and transdermal postmenopausal hormone therapies among women Veterans. Blondon M; Timmons AK; Baraff AJ; Floyd JS; Harrington LB; Korpak AM; Smith NL Menopause; 2021 Jul; 28(10):1125-1129. PubMed ID: 34313612 [TBL] [Abstract][Full Text] [Related]
13. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Harman SM; Black DM; Naftolin F; Brinton EA; Budoff MJ; Cedars MI; Hopkins PN; Lobo RA; Manson JE; Merriam GR; Miller VM; Neal-Perry G; Santoro N; Taylor HS; Vittinghoff E; Yan M; Hodis HN Ann Intern Med; 2014 Aug; 161(4):249-60. PubMed ID: 25069991 [TBL] [Abstract][Full Text] [Related]
14. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH; JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206 [TBL] [Abstract][Full Text] [Related]
15. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials. Swica Y; Warren MP; Manson JE; Aragaki AK; Bassuk SS; Shimbo D; Kaunitz A; Rossouw J; Stefanick ML; Womack CR Menopause; 2018 Jul; 25(7):753-761. PubMed ID: 29381666 [TBL] [Abstract][Full Text] [Related]
16. Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy. Cintron D; Beckman JP; Bailey KR; Lahr BD; Jayachandran M; Miller VM Maturitas; 2017 May; 99():59-65. PubMed ID: 28364870 [TBL] [Abstract][Full Text] [Related]
17. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study. Yuk JS; Kim JM Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757 [TBL] [Abstract][Full Text] [Related]
18. Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke. Lemaitre RN; Weiss NS; Smith NL; Psaty BM; Lumley T; Larson EB; Heckbert SR Arch Intern Med; 2006 Feb; 166(4):399-404. PubMed ID: 16505258 [TBL] [Abstract][Full Text] [Related]
19. Estrogen Therapy and Ischemic Stroke in Women with Diabetes Aged Over 55 Years: A Nation-Wide Prospective Population-Based Study in Taiwan. Chen YH; Hsieh TF; Lee CC; Wu MJ; Fu YC PLoS One; 2015; 10(12):e0144910. PubMed ID: 26658781 [TBL] [Abstract][Full Text] [Related]